187 related articles for article (PubMed ID: 34600538)
1. Next generation sequencing based in-house HIV genotyping method: validation report.
Ayitewala A; Ssewanyana I; Kiyaga C
AIDS Res Ther; 2021 Oct; 18(1):64. PubMed ID: 34600538
[TBL] [Abstract][Full Text] [Related]
2. External Quality Assessment for Next-Generation Sequencing-Based HIV Drug Resistance Testing: Unique Requirements and Challenges.
Lee ER; Gao F; Sandstrom P; Ji H
Viruses; 2020 May; 12(5):. PubMed ID: 32429382
[TBL] [Abstract][Full Text] [Related]
3. Next-Generation Sequencing for HIV Drug Resistance Testing: Laboratory, Clinical, and Implementation Considerations.
Ávila-Ríos S; Parkin N; Swanstrom R; Paredes R; Shafer R; Ji H; Kantor R
Viruses; 2020 Jun; 12(6):. PubMed ID: 32516949
[TBL] [Abstract][Full Text] [Related]
4. Analytical Assessment of the Vela Diagnostics NGS Assay for HIV Genotyping and Resistance Testing: The Apulian Experience.
Bonifacio MA; Genchi C; Lagioia A; Talamo V; Volpe A; Mariggiò MA
Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269868
[TBL] [Abstract][Full Text] [Related]
5. Multi-Laboratory Comparison of Next-Generation to Sanger-Based Sequencing for HIV-1 Drug Resistance Genotyping.
Parkin NT; Avila-Rios S; Bibby DF; Brumme CJ; Eshleman SH; Harrigan PR; Howison M; Hunt G; Ji H; Kantor R; Ledwaba J; Lee ER; Matías-Florentino M; Mbisa JL; Noguera-Julian M; Paredes R; Rivera-Amill V; Swanstrom R; Zaccaro DJ; Zhang Y; Zhou S; Jennings C
Viruses; 2020 Jun; 12(7):. PubMed ID: 32605062
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Vela Diagnostics HIV-1 genotyping assay on an automated next generation sequencing platform.
May S; Adamska E; Tang J
J Clin Virol; 2020 Jun; 127():104376. PubMed ID: 32344322
[TBL] [Abstract][Full Text] [Related]
7. Routine drug resistance testing in HIV-1 proviral DNA, using an automated next- generation sequencing assay.
Alidjinou EK; Coulon P; Hallaert C; Robineau O; Meybeck A; Huleux T; Ajana F; Hober D; Bocket L
J Clin Virol; 2019 Dec; 121():104207. PubMed ID: 31707202
[TBL] [Abstract][Full Text] [Related]
8. Comparison of an
Tzou PL; Ariyaratne P; Varghese V; Lee C; Rakhmanaliev E; Villy C; Yee M; Tan K; Michel G; Pinsky BA; Shafer RW
J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29618499
[TBL] [Abstract][Full Text] [Related]
9. Application of a Sanger-Based External Quality Assurance Strategy for the Transition of HIV-1 Drug Resistance Assays to Next Generation Sequencing.
Jennings C; Parkin NT; Zaccaro DJ; Capina R; Sandstrom P; Ji H; Brambilla DJ; Bremer JW
Viruses; 2020 Dec; 12(12):. PubMed ID: 33348705
[TBL] [Abstract][Full Text] [Related]
10. Limited Marginal Utility of Deep Sequencing for HIV Drug Resistance Testing in the Age of Integrase Inhibitors.
Dalmat RR; Makhsous N; Pepper GG; Magaret A; Jerome KR; Wald A; Greninger AL
J Clin Microbiol; 2018 Dec; 56(12):. PubMed ID: 30305383
[TBL] [Abstract][Full Text] [Related]
11. A MiSeq-HyDRA platform for enhanced HIV drug resistance genotyping and surveillance.
Taylor T; Lee ER; Nykoluk M; Enns E; Liang B; Capina R; Gauthier MK; Domselaar GV; Sandstrom P; Brooks J; Ji H
Sci Rep; 2019 Jun; 9(1):8970. PubMed ID: 31222149
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 Drug Resistance Genotyping in Resource Limited Settings: Current and Future Perspectives in Sequencing Technologies.
Manyana S; Gounder L; Pillay M; Manasa J; Naidoo K; Chimukangara B
Viruses; 2021 Jun; 13(6):. PubMed ID: 34208165
[TBL] [Abstract][Full Text] [Related]
13. Validation of an HIV whole genome sequencing method for HIV drug resistance testing in an Australian clinical microbiology laboratory.
Jenkins F; Le T; Farhat R; Pinto A; Anzari A; Bonsall D; Golubchik T; Bowden R; Lee FJ; van Hal SJ
J Med Virol; 2023 Dec; 95(12):e29273. PubMed ID: 38050831
[TBL] [Abstract][Full Text] [Related]
14. Frequency matters: comparison of drug resistance mutation detection by Sanger and next-generation sequencing in HIV-1.
Balakrishna S; Loosli T; Zaheri M; Frischknecht P; Huber M; Kusejko K; Yerly S; Leuzinger K; Perreau M; Ramette A; Wymant C; Fraser C; Kellam P; Gall A; Hirsch HH; Stoeckle M; Rauch A; Cavassini M; Bernasconi E; Notter J; Calmy A; Günthard HF; Metzner KJ; Kouyos RD
J Antimicrob Chemother; 2023 Mar; 78(3):656-664. PubMed ID: 36738248
[TBL] [Abstract][Full Text] [Related]
15. RNA and DNA Sanger sequencing versus next-generation sequencing for HIV-1 drug resistance testing in treatment-naive patients.
Alidjinou EK; Deldalle J; Hallaert C; Robineau O; Ajana F; Choisy P; Hober D; Bocket L
J Antimicrob Chemother; 2017 Oct; 72(10):2823-2830. PubMed ID: 29091197
[TBL] [Abstract][Full Text] [Related]
16. Next-generation sequencing of dried blood spot specimens: a novel approach to HIV drug-resistance surveillance.
Ji H; Li Y; Graham M; Liang BB; Pilon R; Tyson S; Peters G; Tyler S; Merks H; Bertagnolio S; Soto-Ramirez L; Sandstrom P; Brooks J
Antivir Ther; 2011; 16(6):871-8. PubMed ID: 21900719
[TBL] [Abstract][Full Text] [Related]
17. Dry Panels Supporting External Quality Assessment Programs for Next Generation Sequencing-Based HIV Drug Resistance Testing.
Noguera-Julian M; Lee ER; Shafer RW; Kantor R; Ji H
Viruses; 2020 Jun; 12(6):. PubMed ID: 32575676
[TBL] [Abstract][Full Text] [Related]
18. Prospective Evaluation of the Vela Diagnostics Next-Generation Sequencing Platform for HIV-1 Genotypic Resistance Testing.
Weber J; Volkova I; Sahoo MK; Tzou PL; Shafer RW; Pinsky BA
J Mol Diagn; 2019 Nov; 21(6):961-970. PubMed ID: 31382033
[TBL] [Abstract][Full Text] [Related]
19. Bioinformatic data processing pipelines in support of next-generation sequencing-based HIV drug resistance testing: the Winnipeg Consensus.
Ji H; Enns E; Brumme CJ; Parkin N; Howison M; Lee ER; Capina R; Marinier E; Avila-Rios S; Sandstrom P; Van Domselaar G; Harrigan R; Paredes R; Kantor R; Noguera-Julian M
J Int AIDS Soc; 2018 Oct; 21(10):e25193. PubMed ID: 30350345
[TBL] [Abstract][Full Text] [Related]
20. Performance comparison of next generation sequencing analysis pipelines for HIV-1 drug resistance testing.
Lee ER; Parkin N; Jennings C; Brumme CJ; Enns E; Casadellà M; Howison M; Coetzer M; Avila-Rios S; Capina R; Marinier E; Van Domselaar G; Noguera-Julian M; Kirkby D; Knaggs J; Harrigan R; Quiñones-Mateu M; Paredes R; Kantor R; Sandstrom P; Ji H
Sci Rep; 2020 Jan; 10(1):1634. PubMed ID: 32005884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
